Name of Drug Information System
Annual Meeting Report 2002
Month date, year
Location of meeting
Country
(Insert Logos here)
Name of Drug Information System
Annual Meeting Report 2002
Month date, year
Location of meeting
Country
Prepared by
Author, M. S.
Researcher, Ph.D.
Drug Abuse Unit
Our city Department Of Public Safety
ii
The contents of this report represent the proceedings of the (insert meeting name), held in (insert
meeting venue and date), which was supported by (insert funding and technical support agencies).
For further information, contact: (insert contact details for network coordinator).
(Insert details of the authors and/or name of organization producing the report, publisher and the
place and year of printing.)
For further information and resources on drug information systems, visit the UNDCP Global
Assessment Programme on Drug Abuse web site at www.undcp.org, email gap@undcp.org, or contact:
the Demand Reduction Section, UNDCP, P.O. Box 500, A-1400 Vienna, Austria.
iii
Acknowledgements
iv
Contents
Acknowledgements
Executive summary
I. Introduction
II. Information on drug trends
A. Survey data
B. Existing data sources
C. Qualitative data
D. Overview of drug situation and trends
III. Future directions
A. Policy areas for future development
B. Identification of needs in order to address policy areas
C. Policy implications for drug demand reduction activities
IV. Conclusion and recommendations
Annexes
I. List of participants
II. List of documents
III. Completed Annual Reports Questionnaire and/or regional data collection
questionnaire
v
Executive summary
The executive summary of the report should contain a brief introduction to the network and
meeting report, a general statement summarizing the main findings of the meeting and a brief review of
specific trends for each drug category and other drug-related issues (for example, the number of AIDS
diagnoses, HIV or Hepatitis B and C infection rates, deaths due to drugs and drug-related accidents).
This should then be followed by a summary of recommendations and follow-up action for the network.
If the network meeting report is very brief, it may be more appropriate to provide an abstract
rather than an executive summary. An abstract should be about 150 words in length. It should contain a
general statement of the findings, followed by a one-sentence statement for each drug category and for
any other relevant observations, such as the number of AIDS diagnoses, HIV or Hepatitis B and C
infection rates, deaths due to drugs and drug-related accidents. There should also be a sentence or two
on the main conclusions and recommendations of the meeting.
The structure of the executive summary is reflected in the section headings listed below.
A. Background
B. Summary of the drug situation
C. Recommendations
vi
I. Introduction
A. Country or city information
This should be a short section that describes factors unique to the city or country concerned. It
can include population demographics, based on such factors as age, gender, race and ethnicity, and
briefly describe relevant geographic features and political, economic or social events. Any factors that
could be related to the drug abuse problems should be included.
B. Background to network
II. Information on drug consumption
List the sources and types of data used in the report. Wherever possible, explain any limitations
or caveats on the data elements. For each source, define two time periods that the data cover: the latest
reporting period and the comparison reporting period.
Establish an order for reporting findings from each data source. This order will be used for each
report. The range of data would include the following:
(a) Treatment admissions;
(b) Arrests;
(c) Deaths;
(d) Emergency department episodes;
(e) School or other surveys;
(f) Availability, price and purity;
(g) Seizures;
(h) Trafficking and distribution;
(i) Ethnographic studies, key informant surveys and focus groups;
(j) Special studies.
A suggested order for the presentation of findings is reflected in the headings below.
A. Survey data
1. General population surveys
2. School or youth surveys
3. Specialized or focused surveys
B. Existing data sources
1. Treatment data
2. Arrest and seizure data
3. Other existing data
C. Qualitative data
1. Key informant surveys
2. Focus groups
3. In-depth interviews
4. Ethnographic studies
5. Other
D. Overview of drug situation and trends
2
1. Introduction
This section could be used to give an overall summary of illicit drug use, or of a particular drug
that has become a significant problem, or of one important aspect of the data, such as drug-related
accidents.
2. Primary drug problem
Begin with a statement providing an overview of all indicators and, if possible, of the general
direction of any trend. Elaborate with any qualitative information available, from key informants, focus
groups or ethnographic studies.
Each subsequent paragraph could discuss the data from each data source. For consistency, the
order of the paragraphs could follow the listing of the data sources mentioned above. It would be
helpful to the reader to refer to any tables, charts or other exhibits included in the report.
In addition, a summary of any special studies could be included.
3. Second most important drug (and subsequent drugs)
The same format should be followed as that given above. A description of special studies and
findings would add more detail about some aspect of the drug abuse problem in the city where the
studies occur. University and government researchers in the city who are not part of the integrated drug
information system network may be asked to contribute to this report. Credit for the research and any
funding associated with the studies should be provided.
For the convenience of the reader, all tables, charts and other exhibits should be numbered and
titled. The title should reflect the drug involved, the source of the data, the characteristics studied and
the time period covered.
4. Summary of main trends
III. Future directions
A. Priority areas for future development
B. Identification of needs in order to address priority areas
C. Policy implications for drug demand reduction activities
3
IV. Conclusion and recommendations
4
Annexes
5
I. List of participants
6
II. List of documents
7
III. Completed annual reports questionnaire and/or
regional data collection questionnaire
8